Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 367 | 385 | 14,262 | 18,168 | 211,246 |
| Gross Profit | 367 | 385 | 14,262 | 18,168 | 211,246 |
| Operating Expenses | 26,244 | 29,655 | 29,646 | 57,985 | 59,206 |
| Operating Income | -25,877 | -29,270 | -15,384 | -39,817 | 152,040 |
| Other Income | 2,169 | 4,295 | 6,680 | 6,899 | 6,454 |
| Pre-tax Income | -23,708 | -24,975 | -8,704 | -32,918 | 158,494 |
| Income Tax | N/A | -1,514 | -1,424 | -2,222 | 10,043 |
| Net Income Continuous | -23,708 | -23,461 | -7,280 | -30,696 | 148,451 |
| Net Income | $-23,708 | $-23,461 | $-7,280 | $-30,696 | $148,451 |
| EPS Basic Total Ops | -1.21 | -0.38 | -0.18 | -0.76 | 3.66 |
| EPS Basic Continuous Ops | -1.21 | -0.39 | -0.18 | -0.76 | 3.66 |
| EPS Diluted Total Ops | -1.21 | -0.38 | -0.18 | -0.76 | 3.62 |
| EPS Diluted Continuous Ops | -1.21 | -0.39 | -0.18 | -0.76 | 3.62 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.86 | -0.18 | -0.76 | 3.62 |
| EBITDA(a) | $-25,474 | $-28,870 | $-14,989 | $-39,447 | $152,384 |